Amylin Receptor Agonists
Cagrilintide
Late-stage human trialsInvestigational
Last reviewed: 2026-11-19
History
Novo Nordisk developed cagrilintide; early randomized human results were published in 2021.
Key sources
Primary-reference and editorial check: November 19, 2026. Not an exhaustive clinical review; exact formulations and populations matter.